Baxter International Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 12.15B | 10.06B | 10.36B | 10.64B | 11.24B | 5.7% | |
| Cost of Revenue | (7.43B) | (6.51B) | (6.21B) | (6.65B) | (7.87B) | 18.2% | |
Gross Profit | 4.72B | 3.55B | 4.15B | 3.98B | 3.38B | -15.2% | |
| Operating Expenses | |||||||
| Research & Development | (531.00M) | (450.00M) | (518.00M) | (590.00M) | (518.00M) | -12.2% | |
| Selling, General & Administrative | (2.85B) | (3.10B) | (2.95B) | (2.97B) | (2.89B) | -2.6% | |
| Depreciation & Amortization | (867.00M) | (1.07B) | (984.00M) | (997.00M) | (981.00M) | -1.6% | |
Operating Income (EBIT) | 1.35B | -2.85B | 707.00M | 14.00M | -308.00M | -2300.0% | |
| Non-Operating Items | |||||||
| Interest Income | 14.00M | 19.00M | 69.00M | 67.00M | 52.00M | -22.4% | |
| Interest Expense | (207.00M) | (413.00M) | (508.00M) | (408.00M) | (290.00M) | -28.9% | |
| Other Income/Expenses (Net) | -234.00M | -403.00M | -465.00M | -303.00M | -197.00M | -35.0% | |
Income Before Tax | 1.12B | -3.25B | 242.00M | -289.00M | -505.00M | 74.7% | |
| Income Tax Expense | (83.00M) | (135.00M) | (61.00M) | (37.00M) | (395.00M) | 967.6% | |
Net Income | 1.28B | -2.43B | 2.66B | -649.00M | -957.00M | 47.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $3 | $-5 | $5 | $-1 | $-2 | 37.8% | |
| Weighted Avg Shares Outstanding | 502.00M | 504.00M | 506.00M | 510.00M | 513.00M | 0.6% | |
| Weighted Avg Shares Outstanding (Diluted) | 508.00M | 504.00M | 506.00M | 510.00M | 513.00M | 0.6% | |
EBITDA | 2.19B | -1.76B | 1.73B | 1.12B | 766.00M | -31.4% |
Explore BAX
BAX in the Healthcare
Large Cap